Current through Register Vol. 54, No. 44, November 2, 2024
Section 403.10 - Prohibited manipulation of blood and blood components(a) The following conduct or manipulation is expressly prohibited: (1) The administration or reintroduction of any quantity of autologous, allogenic (homologous) or heterologous blood or red blood cell products of any origin into the circulatory system.(2) Artificially enhancing the uptake, transport or delivery of oxygen, including, but not limited to, perfluorochemicals, efaproxiral (RSR13) and modified hemoglobin products (for example hemoglobin-based blood substitutes, microencapsulated hemoglobin products), excluding supplemental oxygen.(3) Any form of intravascular manipulation of the blood or blood components by physical or chemical means.(b) The chemical and physical manipulation, tampering or attempt to tamper, to alter the integrity and validity of samples collected by the Commission, is prohibited. These methods include but are not limited to urine substitution or adulteration (for example, proteases).(c) Gene doping or any similar conduct with the potential to enhance the horse's performance, is prohibited, including the transfer of polymers of nucleic acids or nucleic acid analogues or the use of normal or genetically modified hematopoietic cells.